Puma Biotechnology(PBYI)

5.135 0.325 6.7568%

今开:4.84昨收:4.81
最高:5.14 最低:4.8308
涨停价:0.0跌停价:0.0
总市值:2.47706495E8

Puma Biotechnology的热门讨论

其他

Puma Biotechnology(PBYI)04-26 20:15

$Puma Biotechnology(PBYI)$ ARS Annual Report to Security Holders Accession Number: 0001437749-24-013310  Act: 34  Size: 7 MB 网页链接查看全文

当期报告

Puma Biotechnology(PBYI)05-03 04:25

$Puma Biotechnology(PBYI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-014382  Act: 34  Size: 326 KB 网页链接查看全文

持股变动声明

Puma Biotechnology(PBYI)02-15 07:05

$彪马生物技术(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-004218  Size: 7 KB 网页链接查看全文

持股变动声明

Puma Biotechnology(PBYI)02-15 07:05

$彪马生物技术(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-004216  Size: 7 KB 网页链接查看全文

当期报告

Puma Biotechnology(PBYI)03-20 04:15

$彪马生物技术(PBYI)$ 8-K Current report, item 8.01 Accession Number: 0001437749-24-008508  Act: 34  Size: 164 KB 网页链接查看全文

超过5%股东持股披露

Puma Biotechnology(PBYI)03-29 22:45

$Puma Biotechnology(PBYI)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-081657  Act: 34  Size: 322 KB 网页链接查看全文

持股变动声明

Puma Biotechnology(PBYI)02-15 06:55

$彪马生物技术(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-004207  Size: 7 KB 网页链接查看全文

超过5%股东持股披露「修订」

Puma Biotechnology(PBYI)02-14 21:25

$彪马生物技术(PBYI)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001654954-24-001699  Act: 34  Size: 67 KB 网页链接查看全文

当期报告

Puma Biotechnology(PBYI)03-01 05:25

$彪马生物技术(PBYI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-006099  Act: 34  Size: 391 KB 网页链接查看全文

持股变动声明

Puma Biotechnology(PBYI)03-20 09:05

$彪马生物技术(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-008575  Size: 7 KB 网页链接查看全文

1 2

Puma Biotechnology的公告

季度财报

$Puma Biotechnology(PBYI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-014395  Act: 34  Size: 7 MB 网页链接

当期报告

$Puma Biotechnology(PBYI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-014382  Act: 34  Size: 326 KB 网页链接

其他

$Puma Biotechnology(PBYI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-24-013311  Act: 34  Size: 396 KB 网页链接

股东委托书协议

$Puma Biotechnology(PBYI)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-24-013309  Act: 34  Size: 3 MB 网页链接

其他

$Puma Biotechnology(PBYI)$ ARS Annual Report to Security Holders Accession Number: 0001437749-24-013310  Act: 34  Size: 7 MB 网页链接

超过5%股东持股披露

$Puma Biotechnology(PBYI)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-081657  Act: 34  Size: 322 KB 网页链接

持股变动声明

$彪马生物技术(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-008575  Size: 7 KB 网页链接

当期报告

$彪马生物技术(PBYI)$ 8-K Current report, item 8.01 Accession Number: 0001437749-24-008508  Act: 34  Size: 164 KB 网页链接

年度财报

$彪马生物技术(PBYI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-006121  Act: 34  Size: 10 MB 网页链接

当期报告

$彪马生物技术(PBYI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-006099  Act: 34  Size: 391 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74